MetLife (MET) has opened 2026 with Q1 revenue of about US$19.1b and basic EPS of US$1.74, setting a clear yardstick for how its profitability is tracking against prior periods. Over recent quarters the company has seen revenue move between roughly US$17.3b and US$23.8b, while basic EPS has ranged from about US$1.04 to US$1.79. This gives you a fuller sense of how this latest print sits within its recent earnings rhythm. With trailing 12 month margins softer than a year ago, this quarter’s results put the spotlight firmly on how efficiently MetLife is converting its top line into profit.

See our full analysis for MetLife.

With the headline numbers set, the next step is to see how these results line up against the widely held narratives about MetLife’s growth, risks, and profitability.

Margins Softer With 4.4% TTM Net Margin

• Over the last 12 months, MetLife converted US$77.6b of revenue into US$3.4b of net income, which works out to a 4.4% net margin compared with 5.9% in the prior year.
• Analysts' consensus view expects earnings to grow about 14.7% per year while revenue is projected to grow around 4.4%. This leans on margin improvement even though the recent trailing margin has eased from 5.9% to 4.4% and five year earnings have declined about 8% per year.
  • Consensus narrative highlights efficiency gains from digital tools and more asset light, fee based businesses, yet the trailing margin data shows profitability has not yet moved in that direction on a reported basis.
  • Forecasts for higher earnings relative to revenue growth sit alongside the recent drop in trailing margin, so you are relying on that margin gap closing rather than stronger top line momentum.

EPS Trend vs Five Year Earnings Decline

• Basic EPS for Q1 2026 of US$1.74 sits within the recent quarterly range of about US$1.04 to US$1.79, while trailing 12 month EPS is US$5.24 compared with US$6.18 a year earlier and a five year earnings decline of about 8% per year.
• Bulls argue that expansion in international markets and digital transformation can support stable, growing earnings, yet the trailing EPS trend and margin compression underline that reported profitability has weakened compared with the earlier 12 month period.
  • The consensus narrative points to growing premium and sales in regions like Asia and Latin America, but trailing net income slipped from US$4.3b to US$3.4b over the last year while revenue moved from US$73.5b to US$77.6b.
  • Claims that asset light, fee based businesses will support more consistent earnings sit against the current 4.4% net margin, which is lower than last year’s 5.9%, so that part of the bullish case is not yet reflected in the reported numbers.

On this mix of softer trailing profitability and upbeat growth forecasts, bulls are leaning heavily on a turnaround in margins rather than on stronger revenue alone. If you want to see how that optimistic case is built out beyond the headline figures, check out the 🐂 MetLife Bull Case

Premium Valuation With 14.8x P/E

• At a share price of US$78.82, the stock trades on a trailing P/E of 14.8x, above both the US Insurance industry average of 11.4x and a peer average of 13.2x, while also sitting well below a DCF fair value of about US$183.78 and alongside a 2.88% dividend yield.
• Bears focus on the combination of weaker trailing profitability and higher leverage, and the fact that the stock trades at a premium P/E multiple despite five year earnings declining about 8% per year and net margin slipping from 5.9% to 4.4% over the last 12 months.
  • Critics highlight that the trailing 12 month net income of US$3.4b and 4.4% margin are below the prior year’s US$4.3b and 5.9%, which can make the 14.8x P/E look demanding compared with industry and peers.
  • The presence of high debt and a premium multiple contrasts with the large gap to the DCF fair value of US$183.78, so bears question whether the weaker trailing earnings profile fully supports both the multiple and the debt load.

If you are weighing whether that higher P/E and leverage outweigh the potential upside implied by DCF fair value, skeptics' detailed arguments around margins, debt, and valuation are worth a closer look in the 🐻 MetLife Bear Case

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for MetLife on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

After weighing both the worries and the upside in this story, it makes sense to move fast and look through the figures yourself so your view is grounded in the data, starting with the 3 key rewards and 1 important warning sign.

Explore Alternatives

MetLife’s softer 4.4% trailing net margin, five year earnings decline, and higher leverage all sit alongside a premium 14.8x P/E multiple.

If you are concerned about that mix of weaker profitability and debt while paying up on valuation, you may want to shift your focus toward companies in the solid balance sheet and fundamentals stocks screener (44 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.